The board of directors of JHBP (CY) Holdings Limited announced that Dr. HAN Shuhua has been appointed as the Chief Scientist of the Group, with effect from 29 January 2021. Dr. Han has over 25 years in drug discovery and academic research in the fields of immunology, cancer immunotherapy, oncology, autoimmune diseases and inflammation.